In this video we discuss longer term results of the phase III SABRINA study, which tested the safety and efficacy of subcutaneous rituximab in patients with follicular lymphoma.
Andrew Davies, PhD
Advertisement
Articles by Andrew Davies, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Supervised Keto Diet/Triplet Chemo Improves Survival in Pancreatic Cancer
2
What Does the Future Hold for Bispecific Antibodies in Multiple Myeloma?
3
The Impact of GLP-1–Mediated Weight Loss on Mammographic Density and Radiomic Risk
4
Exploring Upfront Cytoreductive Radiotherapy in Advanced RCC
5